---
figid: PMC8667582__fphar-12-743073-g002
figtitle: Update on Poly ADP-Ribose Polymerase Inhibitors in Ovarian Cancer With Non-BRCA
  Mutations
organisms:
- NA
pmcid: PMC8667582
filename: fphar-12-743073-g002.jpg
figlink: /pmc/articles/PMC8667582/figure/F2/
number: F2
caption: 'Mechanism of synthetic lethality between HRD and PARP inhibitors. SSBs of
  DNA are normally efficiently repaired by BER. PARP inhibitors prevent the separation
  of PARP from the broken DNA single strand, PARylation is inhibited and the BER pathway
  is impaired, SSBs will persist. A replication fork may encounter persistent SSBs
  during DNA replication, which causes the replication fork to collapse or the formation
  of DSBs. DSBs are usually repaired by HRR, when some key homologous recombination
  genes are damaged or dysregulated, HRD will occur. And then DNA cannot be required,
  or is repaired by alternative pathways that are highly error prone, which results
  in gross genomic instability and cell death. SSB: single-strand breaks; DSB: double-strands
  breaks: BER: base excision repair; HRR: homologous recombination repair; HRD: homologous
  recombination deficiency; NHEJ: non-homologous end joining: MMEJ: microhomology-mediated
  end joining.'
papertitle: Update on Poly ADP-Ribose Polymerase Inhibitors in Ovarian Cancer With
  Non-BRCA Mutations.
reftext: Qin Xu, et al. Front Pharmacol. 2021;12:743073.
year: '2021'
doi: 10.3389/fphar.2021.743073
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: poly ADP-ribose polymerase inhibitors | homologous recombination deficiency
  | ovarian cancer | combination therapy | HRD status detection
automl_pathway: 0.9485264
figid_alias: PMC8667582__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
redirect_from: /figures/PMC8667582__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8667582__fphar-12-743073-g002.html
  '@type': Dataset
  description: 'Mechanism of synthetic lethality between HRD and PARP inhibitors.
    SSBs of DNA are normally efficiently repaired by BER. PARP inhibitors prevent
    the separation of PARP from the broken DNA single strand, PARylation is inhibited
    and the BER pathway is impaired, SSBs will persist. A replication fork may encounter
    persistent SSBs during DNA replication, which causes the replication fork to collapse
    or the formation of DSBs. DSBs are usually repaired by HRR, when some key homologous
    recombination genes are damaged or dysregulated, HRD will occur. And then DNA
    cannot be required, or is repaired by alternative pathways that are highly error
    prone, which results in gross genomic instability and cell death. SSB: single-strand
    breaks; DSB: double-strands breaks: BER: base excision repair; HRR: homologous
    recombination repair; HRD: homologous recombination deficiency; NHEJ: non-homologous
    end joining: MMEJ: microhomology-mediated end joining.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - mtSSB
  - Parp
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Is
  - ber
  - dsb
  - 'On'
  - Cyp6d4
---
